Development and validation of a prognostic model to predict birth weight: individual participant data meta-analysis

出生体重 置信区间 医学 怀孕 荟萃分析 产科 校准 胎龄 人口学 统计 数学 生物 内科学 遗传学 社会学
作者
John Allotey,Lucinda Archer,Kym I E Snell,Dyuti Coomar,Jacques Massé,Line Sletner,Hans Wolf,George Daskalakis,Shigeru Saito,Hannele Laivuori,Akihide Ohkuchi,Hema Mistry,Diane Farrar,Fionnuala Mone,Jun Zhang,Paul T. Seed,Helena Teede,Fabrício da Silva Costa,Athena P. Souka,Richard Hooper,Sergio Ferrazzani,Silvia Salvi,Federico Prefumo,Rinat Gabbay‐Benziv,Chie Nagata,Satoru Takeda,E Sequeira,Olav Lapaire,José Guilherme Cecatti,Katie Morris,Ahmet Baschat,Kjell Å. Salvesen,Luc Smits,Dewi Anggraini,Alice Rumbold,Marleen M. H. J. van Gelder,Arri Coomarasamy,John‏ Kingdom,Seppo Heinonen,Asma Khalil,François Goffinet,Sadia Haqnawaz,Javier Zamora,Richard D. Riley,Shakila Thangaratinam
出处
期刊:BMJ Medicine [BMJ]
卷期号:3 (1): e000784-e000784
标识
DOI:10.1136/bmjmed-2023-000784
摘要

Objective To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Design Individual participant data meta-analysis. Data sources Individual participant data of four cohorts (237 228 pregnancies) from the International Prediction of Pregnancy Complications (IPPIC) network dataset. Eligibility criteria for selecting studies Studies in the IPPIC network were identified by searching major databases for studies reporting risk factors for adverse pregnancy outcomes, such as pre-eclampsia, fetal growth restriction, and stillbirth, from database inception to August 2019. Data of four IPPIC cohorts (237 228 pregnancies) from the US (National Institute of Child Health and Human Development, 2018; 233 483 pregnancies), UK (Allen et al, 2017; 1045 pregnancies), Norway (STORK Groruddalen research programme, 2010; 823 pregnancies), and Australia (Rumbold et al, 2006; 1877 pregnancies) were included in the development of the model. Results The IPPIC birth weight model was developed with random intercept regression models with backward elimination for variable selection. Internal-external cross validation was performed to assess the study specific and pooled performance of the model, reported as calibration slope, calibration-in-the-large, and observed versus expected average birth weight ratio. Meta-analysis showed that the apparent performance of the model had good calibration (calibration slope 0.99, 95% confidence interval (CI) 0.88 to 1.10; calibration-in-the-large 44.5 g, −18.4 to 107.3) with an observed versus expected average birth weight ratio of 1.02 (95% CI 0.97 to 1.07). The proportion of variation in birth weight explained by the model (R 2 ) was 46.9% (range 32.7-56.1% in each cohort). On internal-external cross validation, the model showed good calibration and predictive performance when validated in three cohorts with a calibration slope of 0.90 (Allen cohort), 1.04 (STORK Groruddalen cohort), and 1.07 (Rumbold cohort), calibration-in-the-large of −22.3 g (Allen cohort), −33.42 (Rumbold cohort), and 86.4 g (STORK Groruddalen cohort), and observed versus expected ratio of 0.99 (Rumbold cohort), 1.00 (Allen cohort), and 1.03 (STORK Groruddalen cohort); respective pooled estimates were 1.00 (95% CI 0.78 to 1.23; calibration slope), 9.7 g (−154.3 to 173.8; calibration-in-the-large), and 1.00 (0.94 to 1.07; observed v expected ratio). The model predictions were more accurate (smaller mean square error) in the lower end of predicted birth weight, which is important in informing clinical decision making. Conclusions The IPPIC birth weight model allowed birth weight predictions for a range of possible gestational ages. The model explained about 50% of individual variation in birth weights, was well calibrated (especially in babies at high risk of fetal growth restriction and its complications), and showed promising performance in four different populations included in the individual participant data meta-analysis. Further research to examine the generalisability of performance in other countries, settings, and subgroups is required. Trial registration PROSPERO CRD42019135045

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助收尾人采纳,获得10
1秒前
1秒前
ccm应助曾经的青槐采纳,获得10
1秒前
专注的糖豆完成签到,获得积分10
1秒前
11完成签到 ,获得积分10
2秒前
Pony完成签到,获得积分0
2秒前
111发布了新的文献求助10
4秒前
称心的不言应助YANG采纳,获得10
5秒前
唠叨的胡萝卜完成签到,获得积分10
5秒前
5秒前
搞怪孤丝完成签到 ,获得积分10
5秒前
7秒前
SAINT完成签到,获得积分10
7秒前
8秒前
10秒前
11秒前
iaskwho发布了新的文献求助10
11秒前
111完成签到,获得积分10
12秒前
12秒前
DarrenVan完成签到,获得积分10
15秒前
英俊的铭应助lk采纳,获得10
15秒前
lucky完成签到 ,获得积分10
15秒前
王国科发布了新的文献求助10
16秒前
高高的天亦完成签到 ,获得积分10
16秒前
小D发布了新的文献求助10
17秒前
村上春树的摩的完成签到 ,获得积分10
17秒前
Fox完成签到,获得积分20
18秒前
19秒前
一一完成签到 ,获得积分10
19秒前
20秒前
ccm应助科研通管家采纳,获得10
21秒前
Bio应助科研通管家采纳,获得150
21秒前
无花果应助科研通管家采纳,获得10
21秒前
英姑应助科研通管家采纳,获得10
21秒前
22秒前
ccm应助科研通管家采纳,获得10
22秒前
科目三应助科研通管家采纳,获得10
22秒前
若ruofeng应助科研通管家采纳,获得20
22秒前
dew应助科研通管家采纳,获得10
22秒前
22秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5142180
求助须知:如何正确求助?哪些是违规求助? 4340425
关于积分的说明 13517521
捐赠科研通 4180348
什么是DOI,文献DOI怎么找? 2292405
邀请新用户注册赠送积分活动 1293003
关于科研通互助平台的介绍 1235514